About this trial
Multicenter, randomized open label clinical trial to evaluate IEM and HS as concomitant therapy for respiratory tract infection in patients under artificial ventilation in the ICU.
Lung infection is a serious complication that may occur during hospital stay and may need artificial respiration or even develop during artificial ventilation for other causes.
Current specific treatment consists of intravenous antibiotics. The current study evaluated whether aspiration and drainage of infected sputum helps curing this severe complication and whether nebulized HS has additional benefits, like loosening of secretions, eradicating bacteria or reducing inflammation.
Eligibility criteria
Qualifiers
Signed informed consent
Nosocomial pneumonia (vHAP or VAP) or nosocomial tracheobronchitis
Intubated with a cuffed endotracheal tube or tracheostomy cannula.
Disqualifiers
Ominous prognosis
Frank hemoptisis
Barotrauma (pneumothorax or pneumomediastinum)
Bronchospasm (patients on bronchodilators for previous bronchospasm may be included
Trial design
Treatments tested in this trial
- Mechanical insufflation-exsufflation
- Standard of Care
- Hypertonic saline with hyaluronic acid
Treatment groups
Sponsors and collaborators
Hospital San Carlos, Madrid
Lead sponsor
FUNDACION PARA LA INVESTIGACION HOSPITAL CLINICO SAN CARLOS
Collaborator